The native Franconian has more than 20 years of stock exchange experience and a broadly diversified network.
Before founding his own company, he held various positions as business editor, fund advisor, portfolio manager and finally as CEO of a listed investment company. He also held several positions on the supervisory board.
He is passionate about analyzing a wide variety of business models and investigating new trends, especially in the areas of e-commerce, fintech, blockchain or artificial intelligence.
Commented by Stefan Feulner
Commented by Stefan Feulner on June 25th, 2024 | 08:35 CEST
Covestro, Globex Mining, and Deutz with significant momentum
The rising demand for industrial metals from the renewable energy sector and the increased demand from the defense industry due to the current geopolitical shift pose significant challenges for the Western world. In addition to exploring its own deposits, an improvement in trade relations with China would be desirable. However, following the visit of the Minister of Economic Affairs to China's most important trading partner, this wish has receded into the distant future.
ReadCommented by Stefan Feulner on June 24th, 2024 | 11:15 CEST
Plug Power, Carbon Done Right, Evotec - Turnaround after the price slump
After the price surges in recent weeks, there were initial signs of a temporary top formation in the major US indices, including the Dow Jones, S&P 500, and the tech-heavy Nasdaq. It is hardly surprising, given that these indices have been in overbought territory since the upward trend that began in November. Once again, it is crucial for investors to pick the winners of the coming weeks despite a possible correction.
ReadCommented by Stefan Feulner on June 10th, 2024 | 07:00 CEST
Infineon, MGI - Media and Games Invest, Palantir - These 3 shares are about to break out
Last week was a tough one. Firstly, the European Central Bank heralded the turnaround in interest rates and, as expected, lowered the key interest rate by 25 basis points to 4.25%. Secondly, the hype surrounding meme stocks, and GameStop in particular, was revived by the comeback of influencer Keith Gill, aka Roaring Kitty. Following a live stream on YouTube, the share price soared again and will likely remain a hot topic over the next few trading days.
ReadCommented by Stefan Feulner on June 4th, 2024 | 07:00 CEST
Canopy Growth, Vidac Pharma, BioNTech - Opportunities after the correction
After record highs for the DAX, Dow Jones, and the precious metal gold, the stock market has been burdened by a broad correction in recent days, which could spread further in the coming weeks. However, the setback offers many investors the opportunity to pick up their favorites once again at discounted levels. In addition to the highly volatile cannabis stocks, there are enormous opportunities in the biotech sector, where takeovers are on the rise.
ReadCommented by Stefan Feulner on June 3rd, 2024 | 07:00 CEST
Bloom Energy, Altech Advanced Materials, JinkoSolar - Renewables are booming again
The hype that began at the start of the decade was followed by disillusionment and drastic share price losses. Over the past three years, renewable energy companies such as Plug Power, Nel ASA & Co. have lost disproportionately to the broader market. For some months now, however, many share prices have been showing signs of bottoming out, which could herald the next upward movement. There is no question that hydrogen, photovoltaics, and wind energy technologies will be further expanded in the future.
ReadCommented by Stefan Feulner on May 28th, 2024 | 07:15 CEST
RWE, Desert Gold Ventures, GameStop - Stragglers in the bull market
Despite the fact that the US stock markets were closed yesterday for Memorial Day, Germany's leading index, the DAX, remained in the green. In addition to the major share indices, other asset classes, such as gold and Bitcoin, are generally in an overarching upward trend, which suggests that prices will continue to rise. Although the underlying assets are trading near their highs, companies from the relevant sectors are still far from reaching those levels.
ReadCommented by Stefan Feulner on May 27th, 2024 | 07:30 CEST
Rheinmetall, Saturn Oil + Gas, Canopy Growth - Financial sustainability as a return booster
Sustainability is one of the most significant issues of our time, including on the stock market. In the past, ESG-labeled investments have sprung up like mushrooms. In contrast, investments in socially and ecologically harmful sectors were avoided at the expense of returns. When looking at performance, a striking number of top performers come from sectors such as armaments, oil and gas or cannabis. Listed companies from these sectors are likely to continue their upward trend in the future.
ReadCommented by Stefan Feulner on May 22nd, 2024 | 07:00 CEST
BioNTech, Cardiol Therapeutics, Morphosys - On the verge of a breakout
Compared to the broader indices, DAX and Dow Jones, which have already reached new all-time highs, the Nasdaq Biotech Index is currently lagging. The sector index is still around 23% below its peak from August 2021. Nevertheless, the sector is on the move. In addition to takeovers, which have increased dramatically in 2024, many companies have important study results in the pipeline that could kick-start a rally.
ReadCommented by Stefan Feulner on May 21st, 2024 | 07:00 CEST
Lynas, Almonty Industries, General Motors - Is the trade war escalating, and what is Tesla doing?
The stock markets continue their record-breaking run. The Dow Jones Industrial has climbed to the 40,000-point mark for the first time in its history, and the DAX is also on the verge of breaking through the 19,000-point barrier. So far, so good, one might say. However, something is brewing in the background with regard to the trade war between the US and China, which could put enormous pressure on company margins in the future. As a result, critical commodities, in particular, are likely to be on the verge of a strong upward impulse.
ReadCommented by Stefan Feulner on May 14th, 2024 | 07:30 CEST
Bayer, Defence Therapeutics, Novavax - Major events
The biotechnology sector is still on the move and is currently characterized by a high degree of volatility. For instance, BioNTech, a former star during the pandemic, reported a net loss of EUR 315 million in the first quarter. The Mainz-based biotech now wants to focus more on the development of its cancer drugs due to the slump in demand for COVID-19 vaccines. However, for years, innovative, undiscovered companies have existed in this billion-dollar market that could, with their technologies, become the new high-flyers in the biotech industry.
Read